Results of radiotherapy for lung cancer patients

Radiotherapy for Lung Cancer

The aim of this study was to investigate the relationship between standardized uptake value (SUV), obtained from [18F]fluorodeoxyglucose positron emission tomography (FDG PET), and treatment response and survival of inoperable NSCLC patients treated with high dose radiotherapy. Fifty-one patients were included, recording stage, performance, weight loss, tumour volume, histology, lymph node invo...

Evaluation of Lung Density and Its Dosimetric Impact on Lung Cancer Radiotherapy: A Simulation Study

Background: The dosimetric parameters required in lung cancer radiation therapy are taken from a homogeneous water phantom; however, during treatment, the expected results are being affected because of its inhomogeneity. Therefore, it becomes necessary to quantify these deviations.Objective: The present study has been undertaken to find out inter- and intra- lung density variations and its dosi...

Radiotherapy for Oligometastatic Lung Cancer

Non-small cell lung cancer (NSCLC) typically presents at an advanced stage, which is often felt to be incurable, and such patients are usually treated with a palliative approach. Accumulating retrospective and prospective clinical evidence, including a recently completed randomized trial, support the existence of an oligometastatic disease state wherein select individuals with advanced NSCLC ma...

Radiotherapy in Lung Cancer

Radiotherapy in Lung CanCer

radiotherapy is an important modality in the treatment of lung cancer. in australia, up to 76% of patients have an indication for radiotherapy at diagnosis. this includes curative radiotherapy for patients with inoperable stage i and ii non-small cell lung cancer, and in combination with chemotherapy, for patients with stage iii non-small cell lung cancer and limited stage small cell lung cance...